These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 9713852)
1. Consequences of the combined deficiency in dystrophin and utrophin on the mechanical properties and myosin composition of some limb and respiratory muscles of the mouse. Deconinck N; Rafael JA; Beckers-Bleukx G; Kahn D; Deconinck AE; Davies KE; Gillis JM Neuromuscul Disord; 1998 Aug; 8(6):362-70. PubMed ID: 9713852 [TBL] [Abstract][Full Text] [Related]
2. Analysis of gene expression differences between utrophin/dystrophin-deficient vs mdx skeletal muscles reveals a specific upregulation of slow muscle genes in limb muscles. Baker PE; Kearney JA; Gong B; Merriam AP; Kuhn DE; Porter JD; Rafael-Fortney JA Neurogenetics; 2006 May; 7(2):81-91. PubMed ID: 16525850 [TBL] [Abstract][Full Text] [Related]
3. The sparing of extraocular muscle in dystrophinopathy is lost in mice lacking utrophin and dystrophin. Porter JD; Rafael JA; Ragusa RJ; Brueckner JK; Trickett JI; Davies KE J Cell Sci; 1998 Jul; 111 ( Pt 13)():1801-11. PubMed ID: 9625743 [TBL] [Abstract][Full Text] [Related]
4. Variable cytoplasmic actin expression impacts the sensitivity of different dystrophin-deficient mdx skeletal muscles to eccentric contraction. Lindsay A; Southern WM; McCourt PM; Larson AA; Hodges JS; Lowe DA; Ervasti JM FEBS J; 2019 Jul; 286(13):2562-2576. PubMed ID: 30942954 [TBL] [Abstract][Full Text] [Related]
5. Expression of truncated utrophin leads to major functional improvements in dystrophin-deficient muscles of mice. Deconinck N; Tinsley J; De Backer F; Fisher R; Kahn D; Phelps S; Davies K; Gillis JM Nat Med; 1997 Nov; 3(11):1216-21. PubMed ID: 9359695 [TBL] [Abstract][Full Text] [Related]
6. Does utrophin expression in muscles of mdx mice during postnatal development functionally compensate for dystrophin deficiency? Pons F; Robert A; Marini JF; Léger JJ J Neurol Sci; 1994 Apr; 122(2):162-70. PubMed ID: 8021701 [TBL] [Abstract][Full Text] [Related]
7. Three mouse models of muscular dystrophy: the natural history of strength and fatigue in dystrophin-, dystrophin/utrophin-, and laminin alpha2-deficient mice. Connolly AM; Keeling RM; Mehta S; Pestronk A; Sanes JR Neuromuscul Disord; 2001 Nov; 11(8):703-12. PubMed ID: 11595512 [TBL] [Abstract][Full Text] [Related]
8. Skeletal muscle-specific expression of a utrophin transgene rescues utrophin-dystrophin deficient mice. Rafael JA; Tinsley JM; Potter AC; Deconinck AE; Davies KE Nat Genet; 1998 May; 19(1):79-82. PubMed ID: 9590295 [TBL] [Abstract][Full Text] [Related]
9. Skeletal and cardiac myopathies in mice lacking utrophin and dystrophin: a model for Duchenne muscular dystrophy. Grady RM; Teng H; Nichol MC; Cunningham JC; Wilkinson RS; Sanes JR Cell; 1997 Aug; 90(4):729-38. PubMed ID: 9288752 [TBL] [Abstract][Full Text] [Related]
10. Fast-twitch skeletal muscles of dystrophic mouse pups are resistant to injury from acute mechanical stress. Grange RW; Gainer TG; Marschner KM; Talmadge RJ; Stull JT Am J Physiol Cell Physiol; 2002 Oct; 283(4):C1090-101. PubMed ID: 12225973 [TBL] [Abstract][Full Text] [Related]
12. Prevention of the dystrophic phenotype in dystrophin/utrophin-deficient muscle following adenovirus-mediated transfer of a utrophin minigene. Wakefield PM; Tinsley JM; Wood MJ; Gilbert R; Karpati G; Davies KE Gene Ther; 2000 Feb; 7(3):201-4. PubMed ID: 10694796 [TBL] [Abstract][Full Text] [Related]
13. Expression of a NOS transgene in dystrophin-deficient muscle reduces muscle membrane damage without increasing the expression of membrane-associated cytoskeletal proteins. Tidball JG; Wehling-Henricks M Mol Genet Metab; 2004 Aug; 82(4):312-20. PubMed ID: 15308129 [TBL] [Abstract][Full Text] [Related]
14. Long-term clenbuterol administration alters the isometric contractile properties of skeletal muscle from normal and dystrophin-deficient mdx mice. Hayes A; Williams DA Clin Exp Pharmacol Physiol; 1994 Oct; 21(10):757-65. PubMed ID: 7867226 [TBL] [Abstract][Full Text] [Related]
15. Embryonic myosin is a regeneration marker to monitor utrophin-based therapies for DMD. Guiraud S; Edwards B; Squire SE; Moir L; Berg A; Babbs A; Ramadan N; Wood MJ; Davies KE Hum Mol Genet; 2019 Jan; 28(2):307-319. PubMed ID: 30304405 [TBL] [Abstract][Full Text] [Related]